Bill Ackman Is Still Absolutely Killing It This Year
Reuters/ Eduardo Munoz
Reuters reports that his hedge fund Pershing Square returned 1.4% in September, bringing its year to date return up to 3.15%.
Ackman's most active positions include a big short of Herbalife, which fluctuates between losing him money and going flat; a stake in pharmaceutical company Allergan; and huge stakes Fannie Mae and Freddie Mac - Pershing is the largest shareholder in both stocks.
Fannie and Freddie took a bath this week when a lawsuit to allow shareholders to share in the companies' profits ruled out of hsi favor - both stocks declined up to 40%.
As for Allergan, we'll just have to wait to see how things shake out. Ackman has teamed up with another pharmaceutical company, Valeant, to take over the company. So far Allergan isn't biting.
But the game isn't over yet.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- An Ambani disruption in OTT: At just ₹1 per day, you can now enjoy ad-free content on JioCinema
- Realme C65 5G with 5,000mAh battery, 120Hz display launched starting at ₹10,499
- 8 Fun things to do in Kasol
- SC rejects pleas seeking cross-verification of votes cast using EVMs with VVPAT
- Ultraviolette F77 Mach 2 electric sports bike launched in India starting at ₹2.99 lakh
- Deloitte projects India's FY25 GDP growth at 6.6%
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market